Patent ID: 11905564
Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 0:
1. A method of quantitating an expression level of a lnc-FANCI-2 polynucleotide in a sample containing cells from a test patient's cervix with one or more first polynucleotides that hybridizes to the lnc-FANCI-2 polynucleotide, the method comprising
contacting the sample containing cells from the test patient's cervix with the one or more first polynucleotides, and
detecting the level of hybridization of the one or more first polynucleotides to the lnc-FANCI-2 polynucleotide,
comparing the level of hybridization in the sample containing cells from the test patient's cervix to a control level of hybridization in a control sample of normal cervical tissues, and
determining differential expression of the lnc-FANCI-2 polynucleotide in the sample containing cells from the test patient's cervix when the level of hybridization for the sample containing cells from the test patient's cervix is at least about 150% of the control level of hybridization in the control sample,
wherein the one or more first polynucleotides are SEQ ID NOs: 78, 79 and 80.